TWiV 831: COVID-19 clinical update #89 with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #89, Dr. Griffin reviews upcoming meeting on FDA emergency use authorization for molnupiravir, 25% of US cases in children, reinfection associates with presence of antibodies, national surveillance for acute flaccid myelitis in the US, and monoclonal antibody treatment of infection in vaccinated, high-risk individuals.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Scott Hammer on TWiV 52
- Meeting for molnupiravir EUA (FDA)
- SARS-CoV-2 reinfection associates with antibodies (Clinical Inf Dis)
- AFM surveillance in US (CDC)
- Monoclonal antibody treatment in high-risk patients (J Inf Dis)
- Letters read on TWiV 831
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]